Rheumatoid nodule at an unspecified anatomic site — a firm subcutaneous granulomatous lesion associated with rheumatoid arthritis when the treating provider has not documented or identified the specific body location.

Documentation tips

What should appear in the chart to support M06.30.

Source · Editorial brief grounded in 4 cited references ↓

• Record the anatomic site of the nodule by name (e.g., right olecranon, left proximal forearm) so you can step up to a site-specific M06.31x–M06.39x code instead of the unspecified M06.30.
• Document laterality explicitly (right vs. left) to support the 6th-character level within site-specific subcategories; 'unspecified' laterality is an audit flag for payers.
• Note whether the patient has confirmed seropositive RA (M05.x–) or seronegative/other RA (M06.0x–) and code both conditions when both are addressed at the visit.
• If the nodule is biopsied or excised, ensure the pathology report references rheumatoid granuloma or fibrinoid necrosis consistent with rheumatoid etiology to substantiate M06.30 over a nonspecific soft-tissue lesion code.
• Capture any prior conservative management (corticosteroid injection, DMARDs) in the note history; this supports medical necessity when surgical excision is billed.

Related CPT procedures

Procedure codes commonly billed with M06.30. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M06.30 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M06.30 when site is documented: if the note says 'left elbow nodule,' the correct code is M06.322, not M06.30 — payers increasingly down-code or query unspecified-site claims when clinical context implies a known location.
• Omitting the underlying RA code: rheumatoid nodule is a manifestation of RA; failing to also code the active RA diagnosis (M05.x– or M06.0x–) leaves the clinical picture incomplete and can trigger medical-necessity denials.
• Confusing M06.30 with a generic soft-tissue mass code (e.g., M79.89) — use M06.30 only when rheumatoid nodule is explicitly stated or confirmed by pathology, not as a default for any subcutaneous lump in an RA patient.
• Billing M06.30 as a primary diagnosis for surgical excision without confirming the payer accepts a connective-tissue manifestation code as the principal operative diagnosis; some payers require the active RA code to lead.

Clinical context

Source · Editorial summary grounded in 4 cited references ↓

Sibling codes

Other billable codes under M06.3 (laterality / anatomic variants).